Member Info for Seaking1

Hi Denby69, yes I am please tell.

I’ve just sold Ncyt and got back into bed with ANZ as the sp is low in my opinion if it goes up a good bit it’s then out and depending on sp adding to Oxford Biomedica. That’s the cunning plan, I’m sure I will stuff it up. :-)

I at well be wrong but I think it’s the same contract.

Just bought @8433. Seems a good sp and upward movement (I hope) :-). I will take the vaccine if and when it is made available as I’m 70!

Triumph ,Well I don’t think that will stop AstraZeneca as they have restarted trials in Uk, Brazil, Japan, and other countries. As for Moderna they have never ever made a vaccine.

Sorry if he has caught it but, going by the type of being he is I do not believe it. It’s to convenient.
Bet his doctors got an extra 2million in his bank account. :-).

Looks a strong buy now so I will be topping up Monday.

I don’t believe it. Doesn’t want to go head to head with Biden as he knows he will come off worse.

For once I agree with a broker:-) GSK is an excellent buy , after About 2 years after the split I expect a 30% uplift from my entry point which averages 1650 based on two separate companies,Plus two separate dividends. Just my thinking .

Theoother thing I forgot to mention after the split GSK will still be the biggest vaccine maker in the world and the amalgamation of Phizer/ GSK will be very near if not the biggest healthcare consumables in the world. I checked out Pfizer’s healthcare drugs etc well worth a look, loads and loads.

Thanks for that rogue trader. :-).

I’m hoping that the split will take place as well. When it does I will not be selling as both companies will be very strong. GSK/Phizer with healthcare products pain relief, dental care, Etc. Of which GSK hold 68% of the company. GSK have already been adding to their vaccine side as is shown in past RNSs . Very undervalued at the moment and a massive buy in my view for the future.

Hi Levis ,
My thinking the same as they are the 1st and third biggest vaccine makers on the planet. So it follows on they have the best chance of coming up with a vaccine with their expertise.

Sharehunter, we have just had the interim results. Won’t the q3 results be in say December? Confused.com. :-)

Reading Emma’s comments at the CBI it sounds as though they GSK/Sanfoni May have cracked it ! .

On the move up again. :-)

That was a sell. Someone wants the cash for an extension on the house.:-).

I wonder if the low sp value is in connection with the upcoming split, as giving a valuation may be a stab in the dark?

The sp will go up on confirmation that the trial has been given the go ahead from the FDA to restart.

Chadox1n is the one I’m on which is carried out at Cambridge. There are 3 studies being done as part of the NIHR . Two have multiple hospitals across the country the third is in Hampshire each is aimed at specific age groups as well . I don’t know about other studies being done by biopharma companies. Anyway the info is there if your interested. You don’t at any stage need to actually sign up.